Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Xufeng Lu(Wenzhou Medical University), Y. Eugene Chinn(Binzhou University), Li‐Yan Xu(Shantou University), Xiongbing Zu, Xing S. Fan(Soochow University), Dazhuan E. Xin, Xiaju Cheng(Soochow University), Zhijie Chang(Tsinghua University), Qian Wu(Wenzhou Medical University), Xue Li(Chengdu University of Traditional Chinese Medicine), Man Mohan(Shanghai Jiao Tong University), Juanjuan K. Du(Wenzhou Medical University), Jicheng Yue(Binzhou University), Yu Sun(Dalian Medical University), Ting C. Zhao(Zhejiang Chinese Medical University), Wenhai Deng(Wenzhou Medical University), Yuanyuan Zeng(Sichuan University), Yu Zhang(Wannan Medical College), Xiaomei Lu(Xinjiang Medical University), Zhaoyuan Hou(Binzhou University), Quanli C. Zou(Shanghai Institutes for Biological Sciences), Yanan S. Zhang(Central South University)
Cited by 0
Related Papers
Understanding MAPK Signaling Pathways in Apoptosis
|International Journal of Molecular Sciences|2020|1.2k
Tungsten Sulfide Quantum Dots as Multifunctional Nanotheranostics for <i>In Vivo</i> Dual-Modal Image-Guided Photothermal/Radiotherapy Synergistic Therapy
|ACS Nano|2015|428
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
|International Journal of Clinical Oncology|2017|315